Digital health platform MFine, is set to merge with the diagnostics arm of healthcare and diagnostics solutions provider LifeCell International Private Limited. Following this transaction, LifeCell's diagnostics division and MFine will merge to form LifeWell.
LifeCell is a stem cell bank and provider of reproductive genetic testing services. It claims to be the operator of a national network of advanced genetic testing laboratories serving over 3,000 hospitals in 130 cities, with a primary focus on maternal and newborn health. Following the merger, MFine will remain the app platform and consumer brand providing digital healthcare services and tools. Teleconsultations, care plans, diagnostic tests, e-pharmacy, corporate subscriptions, and other related services will remain available through the MFine app. The funds raised will also be used to make strategic investments in insurance technology and other partners in order to expand MFine's corporate and insurance channel.